CADTH Medical Devices Portfolio Information Session
Health technology assessment (HTA) plays a key role in decisions about the use of medical devices in Canada. This session will cover the role of HTA in the management of medical devices in Canada, the programs in CADTH’s medical devices and clinical interventions portfolio, the assessment processes CADTH follows, and the opportunities for input and engagement by industry, patients, and other stakeholders. Updates on other relevant CADTH initiatives will also be provided. The session will include an Open Forum where attendees can pose questions to CADTH President and CEO Dr. Brian O’Rourke, and other senior staff at CADTH
The session will be presented in English and can be attended in person or by webinar. There is no charge to attend but advance registration is required. Registration closes on Thursday, October 25, 2018.
- Specialty Therapies and Biosimilars Congress
- Jan 22 2020 - Jan 24 2020
- All of the day